Study aim: Evaluation of prophylaxis induced by ivermectin in populations exposed to COVID-19 patients to provide a safe and low-cost way to cure or lowering the consequences of COVID-19 Design: Phase (...) : Inclusion: Healthy individuals exposed directly and constantly with COVID-19 patients. COVID-19 patients who

the prevention of hospitalization and improvement of symptoms of mild covid-19 patients Providing an available and practical treatment to prevent exacerbation of symptoms and hospitalization in mild covid-19 (...) are diagnosed with mild severity of Covid-19. None of the patients, caregivers, researchers, and

Study aim: The efficacy and safety of Ivermectin in patients with COVID-19 Design: Controlled (...) Medical Sciences, Bandar Abbas.The study population is 60 patients with COVID-19 (30 patients in control (...) ≥20 years old (weight ≥35 kg); positive polymerase chain reaction (PCR) test for COVID-19; non

standard treatment protocol for COVID-19 in addition to 6mg Ivermectin tablet made by Alborz Daru Company (...) duration of hospitalization in patients admitted with COVID-19 Design: Clinical trial with control group (...) addition to the standard treatment. Settings and conduct: COVID-19 positive rapid test or RT-PCR patients

was performed in selected outpatient treatment centers of Covid-19 in Shiraz among patients who have (...) clinical manifestations of Covid-19 disease in the age group of 18 to 80 years. Exclusion criteria: Patients with severe clinical signs and symptoms of Covid-19, patients with HIV, patients with severe

micrograms/Kg once every other day for 3 doses plus the usual national protocol of treatment for COVID-19 (...) analyzed using SPSS software. Settings and conduct: In this study, 25 patients with COVID 19 being (...) criteria: 50 patients with COVID 19 disease with no exclusion criteria Exclusion criteria: history of

Study aim: Evaluating the efficacy of ivermectin in the treatment of COVID-19 patients Design (...) study will performe on patients with severe COVID-19 patients admitted to Labbafinejad Hospital in 1401 (...) /Inclusion and exclusion criteria: Inclusion criteria are: Laboratory confirmation of COVID-19 virus by RT

Study aim: Study of Ivermectin effectiveness in the treatment of COVID-19 patients Design: Double (...) sealed envelope method. Participants/Inclusion and exclusion criteria: All Covid-19 patients admitted (...) be placed in 15 blocks of 4. In intervention group (A) they will receive Ivermectin 12 mg/day (Four 3

duration of hospitalization in outpatients with COVID-19 Design: Clinical trial with control group (...) addition to the standard treatment. Settings and conduct: COVID-19 positive rapid test patients referred (...) COVID-19 positive rapid test or RT-PCR age >5 years and weight >15 kg are included in the study

Study aim: purpose of this study is to Determine the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19. Design: clinical trial with control group, with parallel groups (...) hospital. Participants/Inclusion and exclusion criteria: 1. Patients who test positive for COVID-19 by a

COVID-19 To determine the effect of Ivermectin on the recovery of patients infected with COVID-19 To compare the effect of Ivermectin and Metronidazole in the recovery of patients infected with COVID-19 (...) 18 years and older with positive Covid-19 test (infection would be confirmed by RT-PCR or CT-scan

Covid-19 Design: Clinical trial has acontrol group with parallel groups, this study was open label due (...) group, patients receive all available treatments for Covid-19 according to the latest treatment (...) /Inclusion and exclusion criteria: Inclusion criteria: Patients with Covid-19 whose diagnosis is confirmed by

. Participants/Inclusion and exclusion criteria: Inclusion criteria: Positive Covid-19 infection patients who are (...) Study aim: The evaluation of ivermectin effects on treatment coronavirus infections Design: Fifty (...) , patients receive 150 micrograms per kilogram of ivermectin per day based on their body weight for 7 days

Study aim: Clinical trial study of the therapeutic effect of Ivermectin in combination with Kaletra and Chloroquine diet in the treatment of Coronavirus patients in 2019 (COVID-19) Design: Clinical (...) addition to the above drugs, Ivermectin 200–150 μg/kg, is given. Participants/Inclusion and exclusion

Study aim: Evaluating the efficacy and safety of Ivermectin in the treatment of COVID-19 patients (...) reaction to Ivermectin Renal dysfunction Liver dysfunction Pregnancy or deciding to get pregnant or breastfeeding Intervention groups: Intervention group: Receive medication. One ivermectin 14 mg tablet every 12

Study aim: Dose finding of Ivermectin in control and treatment of COVID-19 patients and suggesting it as an antiviral drug against COVID-19 Design: clinical trial with control group, with parallel (...) /Inclusion and exclusion criteria: 1. Patients who test positive for COVID-19 by a commercially available

Study aim: Considering that COVID-19 is associated with high morbidity and mortality and high (...) COVID-19 who have been referred to Ziaian, Imam Khomeini and Baharloo hospitals, after examination by a (...) Medical Centers proven cases of COVID-19 After obtaining informed written consent consciously, they are

consent form from the patient's relatives. Inclusion criteria: Covid 19 PCR test, intubated patient, no (...) Study aim: The goal of this study was to evaluate the effect of adding ivermectin to standard (...) ivermectin or control. Patients become blind due not know the type of gavage drug. Participants/Inclusion

Study aim: Determining the effectiveness of Ivermectin in the treatment of Covid-19 infection in (...) is allocated. Participants/Inclusion and exclusion criteria: Patients with suspected Covid-19 (...) standard treatment and the intervention group will receive a single dose of Ivermectin in addition to the